#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Maarten Frijlink Email
COO . Xenikos
Nijmegen,
LocationPrimary Email
How to contact Maarten Frijlink
Join and see Maarten's contact info for free!Current Roles
Employees:
2Revenue:
$310kAbout
Xenikos, a private, clinical-stage biopharmaceutical company, is focused on developing innovative immunotherapies, based on conjugated antibodies, designed to quickly and safely reset the immune system in patients with a severe immune disease or post-transplantation rejection. Xenikos' flagship product, T-Guard®, is being prepared to enter Phase 3 testing for the treatment of acute graft-versus-host-disease.Xenikos Address
Wilhelminasingel 14Nijmegen, null